{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:47:47Z","timestamp":1793717267440,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12096-7","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T14:54:27Z","timestamp":1765896867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epidemiology of high-risk HPV in Uzbekistan among 44,000 women \u2013 genotypes, risk profiles and screening needs in Uzbekistan"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9734-0795","authenticated-orcid":false,"given":"Malokhat Palvannazirovna","family":"Oltieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7132-0027","authenticated-orcid":false,"given":"Dilfuza Abdullaevna","family":"Alieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitorabonu Bahodir","family":"kizi Abdusattorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9332-4836","authenticated-orcid":false,"given":"Iroda Pulatovna","family":"Sharipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2061-4330","authenticated-orcid":false,"given":"Jasur Ravshanovich","family":"Juraev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohirbek Shokir","family":"ugli Shodiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5124-4353","authenticated-orcid":false,"given":"Erkin Isakovich","family":"Musabaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9036-2744","authenticated-orcid":false,"given":"Mirzarakhim Mirzakhakimovich","family":"Baynazarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9649-7449","authenticated-orcid":false,"given":"Khasanjon Kobiljon","family":"ugli Odilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7485-1218","authenticated-orcid":false,"given":"Nurmuhammad Jaloliddin","family":"ugli Jamoliddinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2986-5660","authenticated-orcid":false,"given":"Ulugbek Khudayberdievich","family":"Mirzaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"12096_CR1","doi-asserted-by":"crossref","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer [Internet]. 2017 Aug 15 [cited 2025 Aug 22];141(4):664. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5520228\/","DOI":"10.1002\/ijc.30716"},{"key":"12096_CR2","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin [Internet]. 2024 May [cited 2025 Aug 22];74(3):229\u201363. Available from: https:\/\/www.cancer.org\/research\/acs-research-news\/cervical-cancer-leads-cancer-deaths-37-countries.html","DOI":"10.3322\/caac.21834"},{"key":"12096_CR3","unstructured":"Human papillomavirus and cancer [Internet]. [cited 2025 Aug 22]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer"},{"key":"12096_CR4","unstructured":"HPV INFORMATION CENTRE [Internet]. [cited 2025 Oct 21]. Available from: https:\/\/hpvcentre.net\/datastatistics.php"},{"key":"12096_CR5","unstructured":"Kongrtay K, Kadrlodinova N, Sultankulova F, Batpanova A, Kim Y, Zhumasheva D, et al. Prevalence of high-grade HPV types among women in Astana, Kazakhstan (2018\u20132022). J Cancer Metastasis Treat. 2023;9:32 [Internet]. 2023 Sep 6 [cited 2025 Aug 22];9(0):N\/A-N\/A. Available from: https:\/\/www.oaepublish.com\/articles\/2394-4722.2023.54"},{"key":"12096_CR6","unstructured":"Aimagambetova G, Azizan A. Epidemiology of HPV infection and HPV-related cancers in Kazakhstan: a review. Asian Pac J Cancer Prev [Internet]. 2018 May 1 [cited 2025 Aug 22];19(5):1175. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6031825\/"},{"key":"12096_CR7","doi-asserted-by":"crossref","unstructured":"Mendoza RP, Haidary T, Gabutan E, Zhou YY, Bukhari Z, Connelly C, et al. Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer. Sci Rep [Internet]. 2021 Dec 1 [cited 2025 Aug 22];11(1):14064. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8263581\/","DOI":"10.1038\/s41598-021-93485-1"},{"key":"12096_CR8","doi-asserted-by":"crossref","unstructured":"Ye Y, Jones T, Wang T, Zeng X, Liu Y, Zhao C. Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions. Gynecology and Obstetrics Clinical Medicine [Internet]. 2024 Apr 1 [cited 2025 Aug 22];4(1):5. Available from: https:\/\/gocm.bmj.com\/content\/4\/1\/e000005","DOI":"10.1136\/gocm-2024-000005"},{"key":"12096_CR9","doi-asserted-by":"crossref","unstructured":"Sharipova IP, Musabaev EI, Sadirova SS, Suyarkulova DT, Tashev SE, Akhmedova SK, et al. Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021\u20132023. J Gynecol Oncol [Internet]. 2025 Jan 1 [cited 2025 Aug 22];36(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39900340\/","DOI":"10.3802\/jgo.2025.36.e7"},{"key":"12096_CR10","doi-asserted-by":"publisher","unstructured":"Gilles C, Konopnicki D, Rozenberg S. The recent natural history of human papillomavirus cervical infection in women living with HIV: a scoping review of meta-analyses and systematic reviews and the construction of a hypothetical model. HIV Med [Internet]. 2023 Aug 1 [cited 2025 Oct 21];24(8):877\u201392. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/hiv.13490","DOI":"10.1111\/hiv.13490"},{"key":"12096_CR11","doi-asserted-by":"crossref","unstructured":"Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. J Clin Virol [Internet]. 2015 Mar 1 [cited 2025 Aug 22];76(Suppl 1):S49. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4789103\/","DOI":"10.1016\/j.jcv.2015.11.015"},{"key":"12096_CR12","unstructured":"HPV and Pap Test Results. Next steps after an abnormal test - NCI [Internet]. [cited 2025 Aug 22]. Available from: https:\/\/www.cancer.gov\/types\/cervical\/screening\/abnormal-hpv-pap-test-results"},{"key":"12096_CR13","doi-asserted-by":"crossref","unstructured":"Alrajjal A, Pansare V, Choudhury MSR, Khan MYA, Shidham VB. Squamous intraepithelial lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System. Cytojournal [Internet]. 2021 [cited 2025 Aug 22];18:16. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8326095\/","DOI":"10.25259\/Cytojournal_24_2021"},{"key":"12096_CR14","doi-asserted-by":"crossref","unstructured":"Liu Y, Yin Y, Zhang Y, Lin L, Zhao M, Chen Q. Diagnostic management of oncogenic HPV cervical infections: the field experience in Wuxi, China. Front Med (Lausanne) [Internet]. 2022 Mar 22 [cited 2025 Aug 22];9:825228. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8984024\/","DOI":"10.3389\/fmed.2022.825228"},{"key":"12096_CR15","doi-asserted-by":"publisher","first-page":"1158270","DOI":"10.3389\/fpubh.2023.1158270","volume":"11","author":"C Roman","year":"2023","unstructured":"Roman C, Andrade D, Hern\u00e1ndez Y, Salazar ZK, Espinosa L, Campoverde E, et al. Biological, demographic, and health factors associated with HPV infection in Ecuadorian women. Front Public Health. 2023;11:1158270.","journal-title":"Front Public Health"},{"key":"12096_CR16","doi-asserted-by":"crossref","unstructured":"Roik E, Sharashova E, Kharkova O, Nieboer E, Postoev V, Odland J. Sociodemographic characteristics, sexual behaviour and knowledge about cervical cancer prevention as risk factors for high-risk human papillomavirus infection in Arkhangelsk, North-West Russia. Int J Circumpolar Health [Internet]. 2018 Jan 1 [cited 2025 Aug 22];77(1):1498681. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6060378\/","DOI":"10.1080\/22423982.2018.1498681"},{"key":"12096_CR17","doi-asserted-by":"crossref","unstructured":"Sharipova IP, Mirzaev UK, Kasimova RI, Yoshinaga Y, Shrapov SM, Suyarkulova DT, et al. Optimizing Human Papillomavirus (HPV) screening: urine sample analysis and associated factors in Uzbekistan. Cureus [Internet]. 2024 Sep 21 [cited 2025 Aug 22];16(9). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39435205\/","DOI":"10.7759\/cureus.69816"},{"key":"12096_CR18","doi-asserted-by":"crossref","unstructured":"Davies P, Aluloski I, Arifdjanova D, Brcanski J, Davidzenka A, Durdyeva A, et al. HPV vaccination and cervical cancer screening policies and practices in 18 countries, territories and entities across Eastern Europe and Central Asia. Asian Pacific Journal of Cancer Prevention [Internet]. 2023 [cited 2025 Aug 22];24(5):1781\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37247301\/","DOI":"10.31557\/APJCP.2023.24.5.1781"},{"key":"12096_CR19","unstructured":"From vaccines to. screenings: how Uzbekistan is transforming cancer care for women [Internet]. [cited 2025 Aug 22]. Available from: https:\/\/www.gavi.org\/vaccineswork\/vaccines-screenings-how-uzbekistan-transforming-cancer-care-women"},{"key":"12096_CR20","unstructured":"Uzbekistan. achieves high HPV vaccination coverage against cervical cancer [Internet]. [cited 2025 Oct 21]. Available from: https:\/\/www.who.int\/europe\/news\/item\/07-09-2022-uzbekistan-achieves-high-hpv-vaccination-coverage-against-cervical-cancer"},{"key":"12096_CR21","doi-asserted-by":"crossref","unstructured":"Chakraborty S, Nessa A, Ferdous NE, Rahman MM, Rashid MHU, Sonia AA, et al. Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh. PLoS One [Internet]. 2024 Dec 1 [cited 2025 Aug 22];19(12):e0313396. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0313396","DOI":"10.1371\/journal.pone.0313396"},{"key":"12096_CR22","doi-asserted-by":"crossref","unstructured":"Sait KH, Anfinan NM, Sait HK, Basalamah HA. Human papillomavirus prevalence and dynamics: insights from a 5-year population-based study in Jeddah, Kingdom of Saudi Arabia. Saudi Med J [Internet]. 2024 Mar 1 [cited 2025 Aug 22];45(3):252. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11115394\/","DOI":"10.15537\/smj.2024.45.3.20230824"},{"key":"12096_CR23","doi-asserted-by":"crossref","unstructured":"Tsakogiannis D, Zografos E, Tzioga L, Zografos CG, Zagouri F, Bletsa G. Prevalence and genotype distribution of high-risk hpv genotypes among women in Greece: a retrospective analysis of 3500 women. Cancers (Basel) [Internet]. 2025 Apr 1 [cited 2025 Aug 22];17(8). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/40282443\/","DOI":"10.3390\/cancers17081267"},{"key":"12096_CR24","unstructured":"Sultana S, Khatun S. Cervical cancer in Asian countries: epidemiology, risk factors and challenges. Int J Reprod Contracept Obstet Gynecol [Internet]. 2025 May 8 [cited 2025 Aug 22];14(6):2035\u201343. Available from: https:\/\/www.ijrcog.org\/index.php\/ijrcog\/article\/view\/15530"},{"key":"12096_CR25","doi-asserted-by":"crossref","unstructured":"Na J, Li Y, Wang J, Wang X, Lu JL, Han S. The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer. Front Microbiol [Internet]. 2023 [cited 2025 Aug 22];14. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37577444\/","DOI":"10.3389\/fmicb.2023.1220522"},{"key":"12096_CR26","doi-asserted-by":"crossref","unstructured":"Su P, Ma J, Yu L, Tang S, Sun P. Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions. Gynecology and Obstetrics Clinical Medicine [Internet]. 2023 Mar 1 [cited 2025 Aug 22];3(1):22\u20139. Available from: https:\/\/gocm.bmj.com\/content\/3\/1\/22","DOI":"10.1016\/j.gocm.2023.01.001"},{"key":"12096_CR27","doi-asserted-by":"crossref","unstructured":"Qin Y, Deng J, Ling Y, Chen T, Gao H. Our experience diagnosing 225 patients with cervical glandular lesions: current technologies, lessons learned, and areas for improvement. Diagn Pathol [Internet]. 2024 Dec 1 [cited 2025 Oct 21];19(1):22. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10811820\/","DOI":"10.1186\/s13000-023-01428-3"},{"key":"12096_CR28","doi-asserted-by":"crossref","unstructured":"Abbas M, de Jonge J, Bettendorf O. Distribution and incidence of atypical glandular lesions in cervical cytology focusing on the association with high-risk human papillomavirus subtypes. Oncol Lett. 2023;25(1).","DOI":"10.3892\/ol.2022.13592"},{"key":"12096_CR29","unstructured":"Global partners cheer. progress towards eliminating cervical cancer and underline challenges [Internet]. [cited 2025 Aug 22]. Available from: https:\/\/www.who.int\/news\/item\/17-11-2023-global-partners-cheer-progress-towards-eliminating-cervical-cancer-and-underline-challenges"},{"key":"12096_CR30","doi-asserted-by":"crossref","unstructured":"Rana T, Chan DNS, Law BMH, Choi KC, Shrestha S, So WKW. Determinants of cervical cancer screening utilisation among women in the least developed countries: A systematic review and meta-analysis. PLoS One [Internet]. 2025 Jun 1 [cited 2025 Aug 22];20(6):e0321627. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0321627","DOI":"10.1371\/journal.pone.0321627"},{"key":"12096_CR31","doi-asserted-by":"crossref","unstructured":"Gopalkrishnan K, Karim R. Addressing global disparities in cervical cancer burden: a narrative review of emerging strategies. Curr HIV\/AIDS Rep [Internet]. 2025 Dec 1 [cited 2025 Aug 22];22(1):18. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11842523\/","DOI":"10.1007\/s11904-025-00727-2"},{"key":"12096_CR32","doi-asserted-by":"crossref","unstructured":"Han C, Huang W, Ye M, Zou R, Lan J, Chen J, et al. HPV prevalence and genotype distribution in 2,306 patients with cervical squamous cell carcinoma in central and eastern China. Front Public Health [Internet]. 2023 [cited 2025 Aug 22];11:1225652. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10493278\/","DOI":"10.3389\/fpubh.2023.1225652"},{"key":"12096_CR33","doi-asserted-by":"crossref","unstructured":"Wei X, Zhang J, Mei Y, Dai Q, Yang X, Wang X. Prevalence and genotype distribution of HPV6\/11\/16\/18 infections among 180,276 outpatient females from a Women\u2019s and Children\u2019s Central Hospital, 2015\u20132021, Chengdu, China. Sci Rep [Internet]. 2023 Dec 1 [cited 2025 Aug 22];13(1):1\u201312. Available from: https:\/\/www.nature.com\/articles\/s41598-023-48222-1","DOI":"10.1038\/s41598-023-48222-1"},{"key":"12096_CR34","doi-asserted-by":"crossref","unstructured":"Aimagambetova G, Chan CK, Ukybassova T, Imankulova B, Balykov A, Kongrtay K, et al. Cervical cancer screening and prevention in Kazakhstan and Central Asia. J Med Screen [Internet]. 2021 Mar 1 [cited 2025 Apr 28];28(1):48\u201350. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31980007\/","DOI":"10.1177\/0969141320902482"},{"key":"12096_CR35","doi-asserted-by":"crossref","unstructured":"Okunade KS, Adejimi AA, John-Olabode SO, Oshodi YA, Oluwole AA. An overview of HPV screening tests to improve access to cervical cancer screening amongst underserved populations: from development to implementation. Risk Manag Healthc Policy [Internet]. 2022 Sep 23 [cited 2025 Aug 22];15:1823\u201330. Available from: https:\/\/www.dovepress.com\/an-overview-of-hpv-screening-tests-to-improve-access-to-cervical-cance-peer-reviewed-fulltext-article-RMHP","DOI":"10.2147\/RMHP.S296914"},{"key":"12096_CR36","doi-asserted-by":"crossref","unstructured":"Catarino R, Petignat P, Dongui G, Vassilakos P. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol [Internet]. 2015 Dec 10 [cited 2025 Aug 22];6(6):281. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4675913\/","DOI":"10.5306\/wjco.v6.i6.281"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12096-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T14:54:31Z","timestamp":1765896871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12096"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12096-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received ethical approval from the Institutional Review Board of the Ministry of Health of Uzbekistan (IRB No. 7\/7-III 65, dated November 30, 2020). All participants provided written informed consent prior to sample collection and questionnaire administration. Data confidentiality was maintained through de-identification procedures and secure data storage protocols in compliance with national and international research ethics guidelines. All research activities were carried out in conformity with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1721"}}